The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Pain Management Drugs-Global Market Insights and Sales Trends 2025

Pain Management Drugs-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1816254

No of Pages : 113

Ask Your Query

Synopsis

Pain is complex, so there are many treatment options -- medications, therapies, and mind-body techniques.

This report is mainly about the drugs for pain management.

The global Pain Management Drugs market size is expected to reach US$ 44550 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Pain Management Drugs in various end use industries. The expanding demands from the Hospitals, Drugstores and Others,, are propelling Pain Management Drugs market. Generic Opioids, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Branded Opioids segment is estimated at % CAGR for the next seven-year period.

The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Pain Management Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Pain Management Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Pain Management Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Pain Management Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Pain Management Drugs covered in this report include GSK, Pfizer, Grunenthal, Sanofi, Bayer, AstraZeneca, Eli Lilly, Endo and Merck, etc.

The global Pain Management Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

  • GSK
  • Pfizer
  • Grunenthal
  • Sanofi
  • Bayer
  • AstraZeneca
  • Eli Lilly
  • Endo
  • Merck
  • Yunnan Baiyao
  • Teikoku Seiyaku
  • Teva
  • J&J
  • Assertio Therapeutics
  • Allergan

Global Pain Management Drugs market, by region:

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, France, UK, Italy, etc.)
  • Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
  • South America (Brazil, etc.)
  • Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Pain Management Drugs market, Segment by Type:

  • Generic Opioids
  • Branded Opioids
  • NSAIDs
  • Others

Global Pain Management Drugs market, by Application

  • Hospitals
  • Drugstores
  • Others

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Pain Management Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

Index

1 Market Overview of Pain Management Drugs
1.1 Pain Management Drugs Market Overview
1.1.1 Pain Management Drugs Product Scope
1.1.2 Pain Management Drugs Market Status and Outlook
1.2 Global Pain Management Drugs Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Pain Management Drugs Market Size by Region (2018-2029)
1.4 Global Pain Management Drugs Historic Market Size by Region (2018-2023)
1.5 Global Pain Management Drugs Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Pain Management Drugs Market Size (2018-2029)
1.6.1 North America Pain Management Drugs Market Size (2018-2029)
1.6.2 Europe Pain Management Drugs Market Size (2018-2029)
1.6.3 Asia-Pacific Pain Management Drugs Market Size (2018-2029)
1.6.4 Latin America Pain Management Drugs Market Size (2018-2029)
1.6.5 Middle East & Africa Pain Management Drugs Market Size (2018-2029)
2 Pain Management Drugs Market by Type
2.1 Introduction
2.1.1 Generic Opioids
2.1.2 Branded Opioids
2.1.3 NSAIDs
2.1.4 Others
2.2 Global Pain Management Drugs Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Pain Management Drugs Historic Market Size by Type (2018-2023)
2.2.2 Global Pain Management Drugs Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Pain Management Drugs Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Pain Management Drugs Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Pain Management Drugs Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Pain Management Drugs Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Pain Management Drugs Revenue Breakdown by Type (2018-2029)
3 Pain Management Drugs Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Drugstores
3.1.3 Others
3.2 Global Pain Management Drugs Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Pain Management Drugs Historic Market Size by Application (2018-2023)
3.2.2 Global Pain Management Drugs Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Pain Management Drugs Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Pain Management Drugs Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Pain Management Drugs Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Pain Management Drugs Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Pain Management Drugs Revenue Breakdown by Application (2018-2029)
4 Pain Management Drugs Competition Analysis by Players
4.1 Global Pain Management Drugs Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Pain Management Drugs as of 2022)
4.3 Date of Key Players Enter into Pain Management Drugs Market
4.4 Global Top Players Pain Management Drugs Headquarters and Area Served
4.5 Key Players Pain Management Drugs Product Solution and Service
4.6 Competitive Status
4.6.1 Pain Management Drugs Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GSK
5.1.1 GSK Profile
5.1.2 GSK Main Business
5.1.3 GSK Pain Management Drugs Products, Services and Solutions
5.1.4 GSK Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.1.5 GSK Recent Developments
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business
5.2.3 Pfizer Pain Management Drugs Products, Services and Solutions
5.2.4 Pfizer Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.2.5 Pfizer Recent Developments
5.3 Grunenthal
5.3.1 Grunenthal Profile
5.3.2 Grunenthal Main Business
5.3.3 Grunenthal Pain Management Drugs Products, Services and Solutions
5.3.4 Grunenthal Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.3.5 Sanofi Recent Developments
5.4 Sanofi
5.4.1 Sanofi Profile
5.4.2 Sanofi Main Business
5.4.3 Sanofi Pain Management Drugs Products, Services and Solutions
5.4.4 Sanofi Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.4.5 Sanofi Recent Developments
5.5 Bayer
5.5.1 Bayer Profile
5.5.2 Bayer Main Business
5.5.3 Bayer Pain Management Drugs Products, Services and Solutions
5.5.4 Bayer Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.5.5 Bayer Recent Developments
5.6 AstraZeneca
5.6.1 AstraZeneca Profile
5.6.2 AstraZeneca Main Business
5.6.3 AstraZeneca Pain Management Drugs Products, Services and Solutions
5.6.4 AstraZeneca Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.6.5 AstraZeneca Recent Developments
5.7 Eli Lilly
5.7.1 Eli Lilly Profile
5.7.2 Eli Lilly Main Business
5.7.3 Eli Lilly Pain Management Drugs Products, Services and Solutions
5.7.4 Eli Lilly Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.7.5 Eli Lilly Recent Developments
5.8 Endo
5.8.1 Endo Profile
5.8.2 Endo Main Business
5.8.3 Endo Pain Management Drugs Products, Services and Solutions
5.8.4 Endo Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.8.5 Endo Recent Developments
5.9 Merck
5.9.1 Merck Profile
5.9.2 Merck Main Business
5.9.3 Merck Pain Management Drugs Products, Services and Solutions
5.9.4 Merck Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.9.5 Merck Recent Developments
5.10 Yunnan Baiyao
5.10.1 Yunnan Baiyao Profile
5.10.2 Yunnan Baiyao Main Business
5.10.3 Yunnan Baiyao Pain Management Drugs Products, Services and Solutions
5.10.4 Yunnan Baiyao Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.10.5 Yunnan Baiyao Recent Developments
5.11 Teikoku Seiyaku
5.11.1 Teikoku Seiyaku Profile
5.11.2 Teikoku Seiyaku Main Business
5.11.3 Teikoku Seiyaku Pain Management Drugs Products, Services and Solutions
5.11.4 Teikoku Seiyaku Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.11.5 Teikoku Seiyaku Recent Developments
5.12 Teva
5.12.1 Teva Profile
5.12.2 Teva Main Business
5.12.3 Teva Pain Management Drugs Products, Services and Solutions
5.12.4 Teva Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.12.5 Teva Recent Developments
5.13 J&J
5.13.1 J&J Profile
5.13.2 J&J Main Business
5.13.3 J&J Pain Management Drugs Products, Services and Solutions
5.13.4 J&J Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.13.5 J&J Recent Developments
5.14 Assertio Therapeutics
5.14.1 Assertio Therapeutics Profile
5.14.2 Assertio Therapeutics Main Business
5.14.3 Assertio Therapeutics Pain Management Drugs Products, Services and Solutions
5.14.4 Assertio Therapeutics Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.14.5 Assertio Therapeutics Recent Developments
5.15 Allergan
5.15.1 Allergan Profile
5.15.2 Allergan Main Business
5.15.3 Allergan Pain Management Drugs Products, Services and Solutions
5.15.4 Allergan Pain Management Drugs Revenue (US$ Million) & (2018-2023)
5.15.5 Allergan Recent Developments
6 North America
6.1 North America Pain Management Drugs Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Pain Management Drugs Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Pain Management Drugs Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Pain Management Drugs Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Pain Management Drugs Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Pain Management Drugs Market Dynamics
11.1 Pain Management Drugs Industry Trends
11.2 Pain Management Drugs Market Drivers
11.3 Pain Management Drugs Market Challenges
11.4 Pain Management Drugs Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock